Increased cardiovascular mortality in hypertensive patients with renal artery stenosis. Relation to sympathetic activation, renal function and treatment regimens

Journal of Hypertension

Volumn 17, Issue 12, 1999, Pages 1743-1750

  Johansson, Mats ^a   Herlitz, Hans ^a   Jensen, Gert ^a   Rundqvist, Bengt ^a   Friberg, Peter ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Hypertension; Renal angioplasty; Renovascular; Sympathetic nervous system

Indexed keywords

NORADRENALIN; RENIN;

ADULT; ANGIOPLASTY; ARTERY RECONSTRUCTION; ARTICLE; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; KIDNEY ANGIOGRAPHY; KIDNEY ARTERY STENOSIS; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; RENIN RELEASE; RENOVASCULAR DISEASE; RISK; SURVIVAL; SWEDEN; SYMPATHETIC TONE;

EID: 0032761683     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199917120-00012     Document Type: Article

References (31)

1. Conlon P, Athirakul K, Kovalik E, Schwab S, Crowley J, Stasck R, et al. Survival in renovascular disease. J Am Soc Nephrol 1998; 9:252-256.
2. Dorros G, Jaff M, Mathiak L, Dorros, II, Lowe A, Murphy K, et al. Four-year follow-up of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis. Circulation 1998; 98:642-647.
3. Cambria R, Brewster D, L'Italien G, Gertler J, Abbot W, LaMuraglia G, et al. Renal artery reconstruction for the preservation of renal function. J Vasc Surg 1996; 24:371-382.
4. Isles C, Main J, O'Connell J, Brown I, Findlay J, Stewart R, et al. Survival associated with renovascular disease in Glasgow and Newcastle: a collaborative study. Scott Med J 1990; 35:70-73.
5. Johansson M, Elam M, Rundqvist B, Eisenhofer G, Herlitz H, Friberg P. Increased sympathetic nerve activity in renovascular hypertension. Circulation 1999; 99:2537-2542.
6. Miyajima E, Yamada Y, Yoshida Y, Matsukawa T, Shionoiri H, Tochikubo O, et al. Muscle sympathetic nerve activity in renovascular hypertension and primary aldosteronism. Hypertension 1991; 17:1057-1062.
7. Swedberg K, Eneroth P, Kjekshus J, Willhelmsen L. Hormones related to cardiovascular function in patients with severe congestive heart failure and thoir relation to mortality. Circulation 1990; 82:173-181.
8. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984; 311:819-823.
9. Ying C, Tifft C, Gavras H, Chobanian A, Renal revascularisation in the azotemic hypertensive patient resistant to therapy. N Engl J Med 1984; 311:1070-1075.
10. Delin K, Aurell M, Granerus G. Preoperative diagnosis of renovascular hypertension. The use of acute stimulation of renin secretion. Acta Med Scand 1984; 215:363-369.
11. Aurell M, Fritjofsson A, Grimby G. Renal extraction of para-aminohippurate during variations in renal blood flow and tubular load in man. Clin Sci 1966; 31:461-471.
12. Granerus G, Moonen M. Effects of extra-renal background subtraction and kidney depth correction in the measurement of GFR by gamma camera renography. Nucl Med Commun 1991; 12:519-527.
13. Hjemdahl P, Daleskog M, Kahan T. Determination of plasma catocholamines by high performance liquid chromatography with electrochemical detection: comparison with a radioenzymatic method. Life Sci 1979; 25:131-138.
14. Eisenhofer G, Goldstein DS, Stull R, Keiser HR, Sunderland T, Murphy DL, et al. Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase, Clin Chem 1986; 32:2030-2033.
15. Giese J, Aurell M, Munck O, Peripheral and renal venous plasma renin concentrations in hypertensive patients with unilateral renal or renovascular disease. Scand J Urol Nephrol 1972; 6 (suppl 15):39-47.
16. Kappelgaard A, Damker Nielsen M, Giese J. Measurement of angiotensin II in human plasma: technical modifications and practical experience. Clin Chem Acta 1976; 67:299-306.
17. Morton J, Webb D, Measurement of plasma angiotensin H, Clin Sci 1985; 68:483-484.
18. Bröchner-Mortensen J. A simple method for the determination of glomerular filtration rate. Scand J Clin Lab Invest 1972; 30:271-274.
19. Jagenburg R, Attman PO, Aurell M, Bucht H. Determination of glomerular filtration rate in advanced renal insufficiency. Scand J Urol Nephrol 1978; 12:133-137.
20. von Knorring J, Lepäntalo M, Fyhrquist F. Long-term prognosis of surgical treatment of renovascular hypertension. J Intern Med 1989; 225:303-309.
21. Grassi G, Cattaneo BM, Seravalle G, Lanfranchi A, Mancia G, Baroreflex control of sympathetic nerve activity in essential and secondary hypertension. Hypertension 1998; 1:68-72.
22. Kaye DM, Lefkovits J, Jennings GL, Bergin P, Broughton A, Esler MD. Adverse consequences of high sympathetic nervous activity in the failing human heart. J Am Coll Cardiol 1995; 26:1257-1263.
23. Shulman NB, Ford CE, Hall WD, Blaufox MD, Simon D, Langford HG, et al. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. Hypertension 1989; 13 (suppl 5):180-193.
24. Ye S, Ozgur B, Campese V. Renal afferent impulses, the posterior hypothalamus, and hypertension in rats with chronic renal failure. Kidney Int 1997; 51:722-727.
25. Converse R Jr, Jacobsen TN, Toto RD, Jost CM, Cosentino F, Fouad-Tarazi F, et al. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 1992; 327:1912-1918,
26. Jensen G, Zachrisson BF, Delin K, Volkmann R, Aurell M. Treatment of renovascular hypertension: one year results of renal angioplasty. Kidney Int 1995; 48:1936-1945.
27. Baumgartner I, Triller J, Mahler F. Patency of percutaneous transluminal renal angioplasty: a prospective sonographic study. Kidney Int 1997; 51:798-803.
28. Randomised trial of intravenous streplokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction: ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet 1988;ii:349-360.
29. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) [see comments]. Lancet 1994; 344:1383-1389.
30. Friberg P, Meredith I, Jennings G, Lambert G, Fazio V, Esler M. Evidence for increased renal norepinephrine overflow during sodium restriction in humans. Hypertension 1990, 16:121-130.
31. Krekels M, Schaper N, de Leeuw P. Sensitivity of blood pressure and renin activation during sodium restriction. Hypertension 1997; 30:1216-1222.